Table 2.
Door-to-Needle Time ≤60 minutes and Door-to-Needle Time ≤45 minutes by Sex and Race/ethnicity
| DTNT≤60 vs. DTNT>60 | DTNT≤45 vs. DTNT<45 | |||
|---|---|---|---|---|
| aOR1 (95% CI) | aOR2 (95% CI) | aOR3 (95% CI) | aOR3 | |
| Sex | ||||
| F (vs. M) | 0.82 (0.72–0.93) | 0.82 (0.72–0.93) | 0.81 (0.72–0.92) | 0.73 (0.57–0.93) |
| Race/ethnicity | ||||
| (ref: FL-W) | ||||
| FL-B | 0.89 (0.75–1.06) | 0.89 (0.75–1.04) | 0.88 (0.74–1.04) | 0.79 (0.59–1.05) |
| FL-H | 1.16 (0.91–1.47) | 1.15 (0.90–1.46) | 1.14 (0.92–1.41) | 0.94 (0.71–1.23) |
| PR-H | 1.06 (0.69–1.63) | 0.79 (0.44–1.40) | 0.76 (0.42–1.39) | 0.45 (0.17–1.22) |
aOR1: Model 1 adjusts for age, sex, race/ethnicity, and insurance status.
aOR2: Model 2 includes Model 1 + hospital academic status, number of beds, years in GWTG-S, and proportion minority treated.
aOR3: Model 3 includes Model 2 + smoking status, hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, coronary artery disease, peripheral vascular disease, history of stroke or TIA, ambulation status prior to stroke, NIHSS, arrival mode, EMS prenotification and stroke center certification.